Evaluation and Management of Pulmonary Hypertension in Noncardiac Surgery: A Scientific Statement From the American Heart Association
Sudarshan Rajagopal(Duke University), Anjali Vaidya(Patanjali Research Foundation), Nathaniel R. Smilowitz(VA NY Harbor Healthcare System), Ingrid Moreno‐Duarte(The University of Texas Southwestern Medical Center), Kristina Kudelko, Kurt Ruetzler(Outcomes Research Consortium), Evelyn M. Horn(Cornell University), Leonie L. Rose Bovino(Leoni (Germany)), Ioana R. Preston, Kamrouz Ghadimi(Duke University Hospital), Marta Kelava
Cited by 102
Related Papers
Clinical Characteristics of Covid-19 in New York City
|New England Journal of Medicine|2020|2.4k
Tranexamic Acid in Patients Undergoing Noncardiac Surgery
|New England Journal of Medicine|2022|322
Dexmedetomidine for reduction of atrial fibrillation and delirium after cardiac surgery (DECADE): a randomised placebo-controlled trial
|The Lancet|2020|303
The β-Arrestins: Multifunctional Regulators of G Protein-coupled Receptors
|Journal of Biological Chemistry|2016|297
Clinical risk factors for portopulmonary hypertension†
|Hepatology|2008|286